CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-01-11
DOI
10.1038/srep19118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adrenomedullin promotes differentiation of oligodendrocyte precursor cells into myelin-basic-protein expressing oligodendrocytes under pathological conditions in vitro
- (2015) Takakuni Maki et al. Stem Cell Research
- The cleavage pattern of TDP-43 determines its rate of clearance and cytotoxicity
- (2015) Quan Li et al. Nature Communications
- Oligodendrocyte-Encoded HIF Function Couples Postnatal Myelination and White Matter Angiogenesis
- (2014) Tracy J. Yuen et al. CELL
- Dynamic droplets: the role of cytoplasmic inclusions in stress, function, and disease
- (2014) Triana Amen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Glial cells in amyotrophic lateral sclerosis
- (2014) T. Philips et al. EXPERIMENTAL NEUROLOGY
- UBE2E Ubiquitin-conjugating Enzymes and Ubiquitin Isopeptidase Y Regulate TDP-43 Protein Ubiquitination
- (2014) Friederike Hans et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of the VHL/HIF-1 Pathway by DJ-1
- (2014) M. Parsanejad et al. JOURNAL OF NEUROSCIENCE
- Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis
- (2013) Thomas Philips et al. BRAIN
- Impaired Cytoplasmic-Nuclear Transport of Hypoxia-Inducible Factor-1α in Amyotrophic Lateral Sclerosis
- (2013) Yuko Nagara et al. BRAIN PATHOLOGY
- Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders
- (2013) J. Janssens et al. HUMAN MOLECULAR GENETICS
- Aberrant Assembly of RNA Recognition Motif 1 Links to Pathogenic Conversion of TAR DNA-binding Protein of 43 kDa (TDP-43)
- (2013) Akemi Shodai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis
- (2013) Shin H Kang et al. NATURE NEUROSCIENCE
- Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats
- (2013) Maria Nikodemova et al. NEUROBIOLOGY OF DISEASE
- Phenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALS
- (2013) Emiliano Trias et al. Frontiers in Cellular Neuroscience
- Parkin Ubiquitinates Tar-DNA Binding Protein-43 (TDP-43) and Promotes Its Cytosolic Accumulation via Interaction with Histone Deacetylase 6 (HDAC6)
- (2012) Michaeline L. Hebron et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oligodendroglia metabolically support axons and contribute to neurodegeneration
- (2012) Youngjin Lee et al. NATURE
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates
- (2012) Sarah J. Parker et al. NEUROCHEMISTRY INTERNATIONAL
- Conserved Acidic Amino Acid Residues in a Second RNA Recognition Motif Regulate Assembly and Function of TDP-43
- (2012) Akemi Shodai et al. PLoS One
- Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity
- (2012) S. J. Weisberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology
- (2012) Takenari Yamashita et al. Nature Communications
- Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing
- (2011) Mei-Xia Che et al. FASEB JOURNAL
- Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice
- (2011) Lionel M. Igaz et al. JOURNAL OF CLINICAL INVESTIGATION
- ReCLIP (Reversible Cross-Link Immuno-Precipitation): An Efficient Method for Interrogation of Labile Protein Complexes
- (2011) Andrew L. Smith et al. PLoS One
- TDP-43 Redistribution is an Early Event in Sporadic Amyotrophic Lateral Sclerosis
- (2009) Maria Teresa Giordana et al. BRAIN PATHOLOGY
- Characterization of Alternative Isoforms and Inclusion Body of the TAR DNA-binding Protein-43
- (2009) Yoshinori Nishimoto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
- (2009) Hristelina Ilieva et al. JOURNAL OF CELL BIOLOGY
- Structural insights into TDP-43 in nucleic-acid binding and domain interactions
- (2009) P.-H. Kuo et al. NUCLEIC ACIDS RESEARCH
- Enrichment of C-Terminal Fragments in TAR DNA-Binding Protein-43 Cytoplasmic Inclusions in Brain but not in Spinal Cord of Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
- (2008) Lionel M. Igaz et al. AMERICAN JOURNAL OF PATHOLOGY
- TDP-43mutation in familial amyotrophic lateral sclerosis
- (2008) Akio Yokoseki et al. ANNALS OF NEUROLOGY
- Disturbance of Nuclear and Cytoplasmic TAR DNA-binding Protein (TDP-43) Induces Disease-like Redistribution, Sequestration, and Aggregate Formation
- (2008) Matthew J. Winton et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Misfolded proteins partition between two distinct quality control compartments
- (2008) Daniel Kaganovich et al. NATURE
- TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
- (2008) Edor Kabashi et al. NATURE GENETICS
- TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
- (2008) J. Sreedharan et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started